118 related articles for article (PubMed ID: 19781197)
1. [Clinicopathologic analysis of primary synovial sarcoma of prostate].
Li J; Li YY; Teng XD; Xu LM
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):479-80. PubMed ID: 19781197
[No Abstract] [Full Text] [Related]
2. [Adult prostate sarcoma: a clinicopathologic study of 15 cases].
Wang C; Song GX; Zhang WM; Zhang ZH; Fan QH
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):749-53. PubMed ID: 22336158
[TBL] [Abstract][Full Text] [Related]
3. [Synovial sarcoma of tongue: report of a case].
Fu YB; Wang GF; Li BZ
Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):557-8. PubMed ID: 21055038
[No Abstract] [Full Text] [Related]
4. Primary pulmonary synovial sarcoma, a rare primary lung neoplasm: two case reports and review of the current literature.
Jiang J; Zhou J; Ding W
Respirology; 2008 Sep; 13(5):748-50. PubMed ID: 18713096
[TBL] [Abstract][Full Text] [Related]
5. [Basal cell carcinoma of prostate: clinicopathologic analysis of two cases].
Zhu Y; Fan QH; Zhou ZS; Zhang ZH; Wang C; Zhang WM; Song GX
Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):477-8. PubMed ID: 19781196
[No Abstract] [Full Text] [Related]
6. Complete resection of synovial sarcoma of prostatic fascia.
Shirakawa T; Fujisawa M; Gotoh A; Okada H; Arakawa S; Kamidono S
Urology; 2003 Mar; 61(3):644. PubMed ID: 12639671
[TBL] [Abstract][Full Text] [Related]
7. [Primary synovial sarcoma of pericardium: report of a case].
Tao LY; He MX; Bai CG; Jiang H; Feng T; Zheng JM; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):704-5. PubMed ID: 23302317
[No Abstract] [Full Text] [Related]
8. Synovial sarcoma of the prostate.
Williams DH; Hua VN; Chowdhry AA; Laskin WB; Kalapurakal JA; Dumanian GA; Dalton DP
J Urol; 2004 Jun; 171(6 Pt 1):2376. PubMed ID: 15126828
[No Abstract] [Full Text] [Related]
9. Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.
Caso JR; Tsivian M; Mouraviev V; Polascik TJ; Moul JW
BJU Int; 2010 Dec; 106(11):1623-7. PubMed ID: 20553260
[TBL] [Abstract][Full Text] [Related]
10. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients.
Hashimoto T; Yoshioka K; Nagao G; Nakagami Y; Ohno Y; Horiguchi Y; Namiki K; Nakashima J; Tachibana M
Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in synovial sarcoma: a clinicopathologic study of 18 cases.
Yokoyama K; Shinohara N; Kondo M; Mashima T
Jpn J Clin Oncol; 1995 Aug; 25(4):131-4. PubMed ID: 7666589
[TBL] [Abstract][Full Text] [Related]
12. Relationship between primary Gleason pattern on needle biopsy and clinicopathologic outcomes among men with Gleason score 7 adenocarcinoma of the prostate.
Gonzalgo ML; Bastian PJ; Mangold LA; Trock BJ; Epstein JI; Walsh PC; Partin AW
Urology; 2006 Jan; 67(1):115-9. PubMed ID: 16413345
[TBL] [Abstract][Full Text] [Related]
13. Despite PSA screening and the control by radical prostatectomy, patients treatment fails and have a PSA recurrence.
Lotan Y
Eur Urol; 2007 Aug; 52(2):453-4. PubMed ID: 17674436
[No Abstract] [Full Text] [Related]
14. Establishment of a synovial sarcoma model in athymic nude mice.
Steinstraesser L; Hauk J; Jacobsen F; Stricker I; Steinau HU; Al-Benna S
In Vivo; 2011; 25(2):165-9. PubMed ID: 21471530
[TBL] [Abstract][Full Text] [Related]
15. This paper evaluates the natural history of prostate cancer in heterogeneous cohort of men treated with HT.
Yossepowitch O
Eur Urol; 2007 Aug; 52(2):453. PubMed ID: 17674435
[No Abstract] [Full Text] [Related]
16. Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy.
Tollefson MK; Slezak JM; Leibovich BC; Zincke H; Blute ML
Mayo Clin Proc; 2007 Apr; 82(4):422-7. PubMed ID: 17418069
[TBL] [Abstract][Full Text] [Related]
17. Biochemical remission after resection of prostate cancer lung metastasis.
Chao DH; Higgins JP; Brooks JD
Urology; 2004 Mar; 63(3):584-5. PubMed ID: 15028469
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
19. PSA recurrence after brachytherapy for seed misplacement: a double-blind radiologic and pathologic work-up after salvage prostatectomy.
Gacci M; Serni S; Lapini A; Vittori G; Vignolini G; Nesi G; Carini M
Prostate Cancer Prostatic Dis; 2008; 11(1):99-101. PubMed ID: 17923856
[TBL] [Abstract][Full Text] [Related]
20. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
Stamey TA
Urologe A; 1990 Mar; 29(2):52-64. PubMed ID: 1691883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
